Health economic assessment of universal immunization of toddlers against Hepatitis A Virus (HAV) in Mexico

References

• WHO position paper on hepatitis A vaccines - June 2012. Wkly Epidemiol Rec 2012; 87:261-76; PMID:22905367
   PubMedGoogle Scholar
• Brundage SC, Fitzpatrick AN. Hepatitis A. Am Fam Physician 2006; 73:2162-8; PMID:16848078
   PubMed Web of Science ®Google Scholar
• Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine 2010; 28:6653-7; PMID:20723630; http://dx.doi.org/10.1016/j.vaccine.2010.08.037
   PubMed Web of Science ®Google Scholar
• Tapia-Conyer R, Santos JI, Cavalcanti AM, Urdaneta E, Rivera L, Manterola A, Potin M, Ruttiman R, Tanaka KJ. Hepatitis A in Latin America: a changing epidemiologic pattern. Am J Trop Med Hyg 1999; 61:825-9; PMID:10586919
   PubMed Web of Science ®Google Scholar
• Valdespino JL, Ruiz-Gómez J, Olaiz-Fernández G, Arias-Toledo E, Conde-González CJ, Palma O, Sepúlveda J. Seroepidemiology of hepatitis A in Mexico. A detector of social inequity and monitor of immunization policies. Salud Publica Mex 2007; 49:S377-85; http://dx.doi.org/10.1590/S0036-36342007000900009
   Web of Science ®Google Scholar
• Rivas-Oropeza I, Valencia-Mendoza A, Sánchez-González G. Carga financiera por hepatitis A en México. Value Health 2009; 12:A516; http://dx.doi.org/10.1016/S1098-3015(10)75446-2
   Google Scholar
• Daniels D, Grytdal S, Wasley A. Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveill Summ 2009; 58:1-27; PMID:19478727
   PubMedGoogle Scholar
• Dagan R, Leventhal A, Anis E, Slater P, Ashur Y, Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA 2005; 294:202-10; PMID:16014594; http://dx.doi.org/10.1001/jama.294.2.202
   PubMed Web of Science ®Google Scholar
• Chodick G, Heymann AD, Ashkenazi S, Kokia E, Shalev V. Long-term trends in hepatitis A incidence following the inclusion of Hepatitis A vaccine in the routine nationwide immunization program. J Viral Hepat 2008; 15 Suppl 2:62-5; PMID:18837837; http://dx.doi.org/10.1111/j.1365-2893.2008.01032.x
   PubMed Web of Science ®Google Scholar
• Vacchino MN. Incidence of hepatitis A in Argentina after vaccination. J Viral Hepat 2008; 15(Suppl 2):47-50; PMID:18837834; http://dx.doi.org/10.1111/j.1365-2893.2008.01029.x
   PubMed Web of Science ®Google Scholar
• Van Effelterre T, De Antonio-Suarez R, Cassidy A, Romano-Mazzotti L, Marano C. Model-based projections of the population-level impact of hepatitis A vaccination in Mexico. Hum Vaccin Immunother 2012; 8:1099-108; PMID:22854667; http://dx.doi.org/10.4161/hv.20549
   PubMed Web of Science ®Google Scholar
• Consejo de Salubridad General. Cuadro Básico y Catálogo de Medicamentos del Sector Salud en México, Edición 2013. 2013 [cited 2014 Oct 17]. Available from: http://www.csg.gob.mx/contenidos/CB2013/medicamentos/med2013
   Google Scholar
• International Monetary Fund. World Economic Outlook Database, October 2013. 2013 Available from: http://www.imf.org/external/pubs/ft/weo/2013/02/weodata/weorept.aspx?sy=2011&ey=2013&scsm=1&ssd=1&sort=country&ds=.&br=1&c=273&s=NGDPPC&grp=0&a=&pr.x=40&pr.y=15
   Google Scholar
• Jacobs RJ, Greenberg DP, Koff RS, Saab S, Meyerhoff AS. Regional variation in the cost effectiveness of childhood hepatitis A immunization. Pediatr Infect Dis J 2003; 22:904-14; PMID:14551492; http://dx.doi.org/10.1097/01.inf.0000091295.53969.6a
   PubMed Web of Science ®Google Scholar
• Rein DB, Hicks KA, Wirth KE, Billah K, Finelli L, Fiore AE, Hoerger TJ, Bell BP, Armstrong GL. Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States. Pediatrics 2007; 119:e12-e21; PMID:17200237; http://dx.doi.org/10.1542/peds.2006-1573
   PubMed Web of Science ®Google Scholar
• Valenzuela MT, Jacobs RJ, Arteaga O, Navarrete MS, Meyerhoff AS, Innis BL. Cost-effectiveness of universal childhood hepatitis A vaccination in Chile. Vaccine 2005; 23:4110-9; PMID:15964479; http://dx.doi.org/10.1016/j.vaccine.2005.03.021
   PubMed Web of Science ®Google Scholar
• Quezada A, Baron-Papillon F, Coudeville L, Maggi L. Universal vaccination of children against hepatitis A in Chile: a cost-effectiveness study. Rev Panam Salud Publica 2008; 23:303-12; PMID:18510790; http://dx.doi.org/10.1590/S1020-49892008000500002
   PubMed Web of Science ®Google Scholar
• Zahdi MR, Maluf I, Jr, Maluf EM. Hepatitis A: the costs and benefits of the disease prevention by vaccine, Parana, Brazil. Braz J Infect Dis 2009; 13:257-61; PMID:20231986; http://dx.doi.org/10.1590/S1413-86702009000400003
   PubMed Web of Science ®Google Scholar
• Ellis A, Ruttimann RW, Jacobs RJ, Meyerhoff AS, Innis BL. Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted. Rev Panam Salud Publica 2007; 21:345-56; PMID:17761046; http://dx.doi.org/10.1590/S1020-49892007000500002
   PubMed Web of Science ®Google Scholar
• Van Herck K, Jacquet JM, Van Damme P. Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years. J Med Virol 2011; 83:1885-91; PMID:21915861; http://dx.doi.org/10.1002/jmv.22200
   PubMed Web of Science ®Google Scholar
• Van Herck K. Crasta PD, Messier M, Hardt K, Van Damme P. Seventeen-year antibody persistence in adults primed with two doses of an inactivated hepatitis A vaccine. Hum Vaccin Immunother 2012; 8:323-7; PMID:22327499; http://dx.doi.org/10.4161/hv.18617
   PubMedGoogle Scholar
• Van Damme P, Theeten H, Van Der Meeren O, Crasta P, Van Herck K. Does hepatitis A vaccine confer life-long protection? 5th Northern European Conference on Travel Medicine, Bergen, 5–8 June 2014
   Google Scholar
• SINAVE/DGE/SALUD. Perfil epidemiológico de la Infancia en México 2010. Junio; 2011
   Google Scholar
• Sistema Único de Información para la Vigilancia Epidemiológica (SUIVE)/Dirección General de Epidemiología/Secretaría de Salud. Anuarios de morbilidad, 1998-2013. 2014 [cited 2014 Oct 25]. Available from: http://www.dgepi.salud.gob.mx/anuario/html/anuarios.html
   Google Scholar
• Ciocca M. Clinical course and consequences of hepatitis A infection. Vaccine 2000; 18(Suppl 1):S71-4; PMID:10683554; http://dx.doi.org/10.1016/S0264-410X(99)00470-3
   PubMed Web of Science ®Google Scholar
• Ott JJ, Wiersma ST. Single-dose administration of inactivated hepatitis A vaccination in the context of hepatitis A vaccine recommendations. Int J Infect Dis 2013; 17:e939-44; PMID:23791857; http://dx.doi.org/10.1016/j.ijid.2013.04.012
   PubMed Web of Science ®Google Scholar
• Vizzotti C, Gonzalez J, Gentile A, Rearte A, Ramonet M, Canero-Velasco MC, Perez Carrega ME, Uruena A, Diosque M. Impact of the single-dose immunization strategy against hepatitis A in Argentina. Pediatr Infect Dis J 2014; 33:84-8; PMID:24352191; http://dx.doi.org/10.1097/INF.0000000000000042
   PubMed Web of Science ®Google Scholar
• Pham B, Chen MH, Tricco AM, Anonychuk A, Krahn M, Bauch CT. Use of a catalytic model to estimate hepatitis A incidence in a low-endemicity country: implications for modeling immunization policies. Med Decis Making 2012; 32:167-75; PMID:21393559; http://dx.doi.org/10.1177/0272989X11398489
   PubMed Web of Science ®Google Scholar
• Armstrong GL, Bell BP. Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization. Pediatrics 2002; 109:839-45; PMID:11986444; http://dx.doi.org/10.1542/peds.109.5.839
   PubMed Web of Science ®Google Scholar
• Abarca K, Ibanez I, Perret C, Vial P, Zinsou JA. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children. Int J Infect Dis 2008; 12:270-7; PMID:17988917; http://dx.doi.org/10.1016/j.ijid.2007.08.006
   PubMed Web of Science ®Google Scholar
• Noskova AV, Gorbunov MA, Pavlova LI, El'shina GA, Sharipova IS, Karpovich LG, Kalashnikova TI, Bektimirov TA, Rikhmer VV, El'nikov VS. Comparative study of the reactivity, safety and immunogenicity of “Havrix” inactivated hepatitis A vaccine. Vopr Virusol 2000; 45:42-4; PMID:11200647
   PubMedGoogle Scholar
• Poovorawan Y, Kosuwon P, Sutra S, Theamboonlers A, Vimolket T, Safary A. Comparison of the reactogenicity and immunogenicity of two different dose levels of hepatitis A vaccine in healthy children and adolescents. Asian Pac J Allergy Immunol 1998; 16:111-7; PMID:9876949
   PubMed Web of Science ®Google Scholar
• Summary of Product Characteristics. Havrix Junior Monodose vaccine. 2011 Aug 22 [cited 2011 Nov 3]. Available from: http://www.medicines.org.uk/emc/medicine/2040/SPC/
   Google Scholar
• Dirección General de Información en Salud (DGIS). Base de datos de egresos hospitalarios por morbilidad en Instituciones Públicas, 2004-2013. 2014 [cited 2014 Oct 25]. Available from: http://www.sinais.salud.gob.mx
   Google Scholar
• Centro Nacional de Trasplantes. Estado actual de donación y trasplantes en México. Reporte anual 2013; 2013
   Google Scholar
• Portal de compras del Instituto Mexicano del Seguro Social (IMSS). 2013 [cited 2013 Dec 20]. Available from: http://compras.imss.gob.mx/
   Google Scholar
• Muciño-Ortega E, Mould-Quevedo JF, Farkouh R, Strutton D. Economic evaluation of an infant immunization program in Mexico, based on 13-valent pneumococcal conjugated vaccines. Value Health 2011; 14:S65-S70; PMID:21839902; http://dx.doi.org/10.1016/j.jval.2011.05.025
   PubMedGoogle Scholar
• Instituto Mexicano del Seguro Social. Costos unitarios por nivel de atención médica para el año 2012. Diario Oficial de la Federación, Miércoles 9 de mayo de 2012; 2012
   Google Scholar
• Instituto Mexicano del Seguro Social. Grupos Relacionados con el Diagnóstico 2013 [cited 2013 Dec 20]. Available from: http://www.imss.gob.mx/profesionales/Documents/GRD_IMSS.pdf
   Google Scholar
• Instituto Nacional de Estadística y Geografía. Mujeres y Hombres en México 2011. Instituto Nacional de las Mujeres. México: INEGI 2012; xxxii, 218 p.:il
   Google Scholar
• Instituto Nacional de Estadística y Geografía. Encuesta Nacional de Ocupación y Empleo. Consulta interactiva de datos para los cuatro trimestres del año 2012. 2012 Available from: http://www.inegi.org.mx/sistemas/olap/proyectos/bd/consulta.asp?p=27608&c=27221&s=est&cl=4#
   Google Scholar
• Luyten J, Marais C, Hens N, De Schrijver K, Beutels P. Imputing QALYs from single time point health state descriptions on the EQ-5D and the SF-6D: a comparison of methods for hepatitis a patients. Value Health 2011; 14:282-90; PMID:21296602; http://dx.doi.org/10.1016/j.jval.2010.10.004
   PubMed Web of Science ®Google Scholar
• Consejo de Salubridad General. Guía de Evaluación de Insumos para la Salud. Edición 2011. Mexico 2011
   Google Scholar
• Banco de México. Tipos de Cambio Peso/Dólar durante el Año 2012. 2014 [cited 2014 Dec 20]. Available from: http://www.banxico.org.mx/portal-mercado-cambiario/index.html
   Google Scholar